New Migraine Drugs Significantly Reduce Headache Days, Side Effects Noted

Recent research shows that a new class of migraine drugs (CGRP inhibitors) can effectively reduce monthly headache days, but may cause side effects like fatigue and nausea. Experts advise patients to weigh benefits and risks under medical guidance.

migrainenew drughealthresearchside effects

Research Background

Migraine is a common neurological disorder affecting hundreds of millions worldwide. Traditional treatments have limited efficacy and notable side effects. In recent years, new drugs targeting calcitonin gene-related peptide (CGRP) have become a research focus.

Key Findings

Clinical trials show that CGRP inhibitors can reduce monthly headache days by an average of 2-4 days, with some patients experiencing greater benefits. Common side effects include:

Fatigue
Nausea
Injection site reactions
Constipation

Expert Advice

Doctors emphasize that the new drugs are not suitable for all patients. Treatment plans should be made under neurological specialist evaluation, considering individual conditions and tolerance. Long-term safety requires further research.